Professional Documents
Culture Documents
consumer_quinine_qualaquin
Reviewed on 8/27/2021
Quinine is a prescription drug used as an antimalarial drug indicated only for the treatment of
uncomplicated Plasmodium falciparum malaria. Quinine sulfate has been shown to be
effective in geographical regions where resistance to chloroquine has been documented.
Dosage of Quinine:
Capsule
324 mg
Dosage Considerations – Should be Given as Follows:
Malaria
Adults
648 mg orally every 8 hours for 3-7 days concomitant tetracycline, doxycycline, or
clindamycin
648 mg orally every 8 hours for 3-7 days concomitant doxycycline (or tetracycline) and
oral primaquine
Pediatric Dosages
30 mg/kg/day orally divided three times daily for 3-7 days, with concomitant doxycycline,
tetracycline, or clindamycin
Babesiosis
Adult Dosage:
Pediatric Dosage:
25 mg/kg/day orally divided three times daily for 7 days, with concomitant oral
clindamycin
Dosage Modifications
Severe, chronic renal impairment: 648 mg orally once, then 324 mg orally every 12 hours
Hepatic impairment
QUESTION
See Answer
WHAT ARE SIDE EFFECTS ASSOCIATED WITH USING QUININE?
chest pain
fever
rash
itching
hepatitis
night blindness
double vision
impaired hearing
hypersensitivity reaction
severe headache
nausea
vomiting
diarrhea
blurred vision
sweating
ringing in the ears (tinnitus)
abdominal pain
deafness
blindness
irregular heartbeats
weakness
Lupus-like syndrome
bleeding
bleeding disorder
reduction of red and white blood cells and platelets in the blood
lupus anticoagulant
confusion
seizures
coma
disorientation
shakiness
restlessness
acute involuntary contractions of muscles in the face, neck, trunk, pelvis, and extremities
communication disorder
suicide
hives
blistering rash
sensitivity to light
asthma
shortness of breath
atrioventricular block
delayed heartbeat
ventricular fibrillation
torsades de pointes
cardiac arrest
granulomatous hepatitis
loss of appetite
muscle pain
muscle weakness
kidney failure
kidney impairment
visual disturbances
light sensitivity
This document does not contain all possible side effects and others may occur. Check with
your physician for additional information about side effects.
If your doctor has directed you to use this medication, your doctor or pharmacist may already
be aware of any possible drug interactions and may be monitoring you for them. Do not start,
stop, or change the dosage of any medicine before checking with your doctor, health care
provider, or pharmacist first.
cisapride
dronedarone
eliglustat
pimozide
thioridazine
This information does not contain all possible interactions or adverse effects. Therefore,
before using this product, tell your doctor or pharmacist of all the products you use. Keep a
list of all your medications with you, and share this information with your doctor and
pharmacist. Check with your health care professional or doctor for additional medical advice,
or if you have health questions, concerns, or for more information about this medicine.
Chronic renal impairment associated with the development of TTP has been reported
This medication contains quinine. Do not take Qualaquin if you are allergic to quinine or
any ingredients contained in this drug
Keep out of reach of children. In case of overdose, get medical help or contact a Poison
Control Center immediately
Contraindications
Hypersensitivity
G6PD deficiency
Pregnancy
No information available
Short-Term Effects
Long-Term Effects
Reduce parenteral dose by half if over 48-hour parenteral treatment required; monitor
EKG, blood pressure, and glucose with parenteral treatment
FDA warns against unapproved use for leg cramps because of unpredictable serious and
life-threatening hematologic reactions including thrombocytopenia and hemolytic-
uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP)
QT prolongation
At particular risk are patients with underlying structural heart disease and preexisting
conduction system abnormalities, elderly patients with sick sinus syndrome, patients
with atrial fibrillation with the slow ventricular response, patients with myocardial
ischemia, or patients receiving drugs known to prolong the PR interval (verapamil) or
QRS interval (flecainide or quinidine)
SLIDESHOW
See Slideshow
References